CD30+ IMMUNOBLASTIC LARGE T-CELL CUTANEOUS LYMPHOMA

Clinical trials for CD30+ IMMUNOBLASTIC LARGE T-CELL CUTANEOUS LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new CD30+ IMMUNOBLASTIC LARGE T-CELL CUTANEOUS LYMPHOMA trials appear

Sign up with your email to follow new studies for CD30+ IMMUNOBLASTIC LARGE T-CELL CUTANEOUS LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

First patients sought for trial of 'Re-Engineered' immune cells to fight advanced blood cancers

Disease control Not yet recruiting

This is a first-in-human study to test the safety and early effectiveness of a new personalized immunotherapy. It is for adults with certain advanced blood cancers (like Hodgkin lymphoma and others) that have a marker called CD30 and have come back or not responded to at least tw…

Matched conditions: CD30+ IMMUNOBLASTIC LARGE T-CELL CUTANEOUS LYMPHOMA

Phase: PHASE1 • Sponsor: Medical College of Wisconsin • Aim: Disease control

Last updated Mar 02, 2026 15:27 UTC

CD30+ IMMUNOBLASTIC LARGE T-CELL CUTANEOUS LYMPHOMA

Get alerted when new CD30+ IMMUNOBLASTIC LARGE T-CELL CUTANEOUS LYMPHOMA trials appear

First patients sought for trial of 'Re-Engineered' immune cells to fight advanced blood cancers